ReviewAdvances in biochemical engineering/biotechnology2026
The Starting Point for Biomolecular Crystallisation.
Review in Advances in biochemical engineering/biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This chapter presents a historical overview and contemporary insights into the crystallisation of biological macromolecules. It looks at what knowledge has been obtained about the crystallisation of small molecules and how it relates to biomolecules. While the principles of supersaturation and nucleation are the same for both, the complexity of biomolecules presents unique challenges to their crystallisation. Before crystallisation experiments begin with the biomolecule, it is advisable to assay the purity, measure the concentration, and choose a suitable solvent formulation. These parameters are not necessarily straightforward to evaluate. Thereafter, the initial crystallisation screening attempts to examine the effects of chemical space, temperature, pH, and kinetics. Because initial screens do not typically produce diffraction-quality crystals, suggestions are offered for how to optimise screening outcomes. In this context, seeding is particularly powerful, on its own, or in synergy with other optimisation techniques. The chapter concludes with the observation that biomolecular crystallisation remains a poorly understood problem. It is proposed that collecting more information about the crystallisation experiments - both the failed and successful ones - may contribute to a better understanding of the process.
Indexed as
Identifiers
41910600What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.